Clinical trial Recruiting at 1 site Interventional Ages 40 to 55 Women only

Effects of melatonin on heart health during menopause

Official title: Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial

Run by Mayo Clinic · NCT06826755 · Data updated 2026-11-12

This study is testing if taking melatonin for 12 weeks can help improve heart health in women aged 40-55 who are going through perimenopause and have high blood pressure.

More Hypertension trials

Quick facts

Study typeInterventional
Ages40 Years to 55 Years
SexWomen only
Enrollment70 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedMay 23, 2025
Main results expectedSeptember 2027
Study endsJanuary 2028
Registry record updatedAugust 13, 2026
Trial IDNCT06826755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 40-55 in the menopause transition with a diagnosis of hypertension.

Probably not a fit

Patients who are currently using prescription sleeping medications or hormonal contraceptives may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of 12 weeks of melatonin supplementation on cardiovascular disease mechanisms in women experiencing perimenopause and hypertension. Participants will receive either melatonin or a placebo to assess changes in blood pressure and related cardiovascular markers. The study aims to determine if melatonin can provide a therapeutic benefit during this transitional phase of menopause. The trial is designed to include women aged 40-55 who meet specific criteria regarding their menstrual cycle and hypertension status.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option for managing hypertension in women undergoing menopause.

How similar studies have gone: While there is limited research specifically on melatonin for cardiovascular health in menopause, similar studies on melatonin's effects on hypertension have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age 40-55 years old
* Female individuals with intact uterus and at least one ovary
* Hypertension

  o Defined as a prior diagnosis of hypertension, use of antihypertensive agents, or office SBP/DBP ≥130/80 mmHg
* On stable medical regimen (≥ 2 months) if taking other medications

Exclusion Criteria

* Prescription sleeping medications or melatonin supplementation
* Pregnant or lactating
* Use of tobacco, nicotine or vaping products
* Night shift work
* On prescription aspirin
* Severe lactose intolerance
* History of substance use disorder
* History of suicidal ideation
* History of clinically diagnosed anemia (within the past 5 years) or low hemoglobin levels (\<11.6 g/dL) within the past 12 months
* Active cancer
* Severe daytime sleepiness (score \>15 at the Epworth Sleepiness Scale \[ESS\])81
* Current or recent (within the past 2 months) participation in other research studies at the discretion of study investigators
* Inability to provide written consent and/or to speak and read English
* Any other medical, geographic, or social factor making study participation impractical

Where it's running

  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.